Endologix, Inc. (ELGX) Financial Statements (2025 and earlier)

Company Profile

Business Address 2 MUSICK
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 41,56046,58750,9439,69623,531
Cash and cash equivalent 41,56046,58750,9439,69623,531
Restricted cash and investments 1,2001,2001,2001,2001,200
Receivables 22,67421,88722,25826,32820,980
Inventory, net of allowances, customer advances and progress billings 26,40530,87730,74730,20230,399
Inventory 26,40530,87730,74730,20230,399
Other current assets 1,8642,0582,2702,5352,821
Total current assets: 93,703102,609107,41869,96178,931
Noncurrent Assets
Operating lease, right-of-use asset 5,7685,6605,728 
Property, plant and equipment 13,15213,69114,49515,23616,033
Intangible assets, net (including goodwill) 193,417194,264195,278196,117197,011
Goodwill 120,814120,770120,837120,815120,848
Intangible assets, net (excluding goodwill) 72,60373,49474,44175,30276,163
Other noncurrent assets 1,1241,2931,3722,3921,095
Other undisclosed noncurrent assets     5,787 
Total noncurrent assets: 213,461214,908216,873219,532214,139
TOTAL ASSETS: 307,164317,517324,291289,493293,070
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 45,18746,30242,53144,15338,927
Employee-related liabilities 18,23218,73213,83613,17314,627
Accounts payable 14,02411,77912,45414,92310,986
Accrued liabilities 12,93115,79116,24116,05713,314
Debt      
Other undisclosed current liabilities  10,606    
Total current liabilities: 55,79346,30242,53144,15338,927
Noncurrent Liabilities
Long-term debt and lease obligation 183,681176,993165,024203,482198,078
Long-term debt, excluding current maturities  172,060176,993165,024203,482198,078
Liabilities, other than long-term debt 2,89415,32516,58816,29316,269
Accounts payable and accrued liabilities   11,64011,81211,976 
Deferred rent credit      8,065
Deferred income tax liabilities 150150150 
Other liabilities 2,2442,2352,3262,3171,992
Operating lease, liability 11,621   
Business combination, contingent consideration, liability 5001,3002,3002,0002,200
Derivative instruments and hedges, liabilities      4,012
Other undisclosed noncurrent liabilities  9409,11228,0726,185150
Total noncurrent liabilities: 187,515201,430209,684225,960214,497
Total liabilities: 243,308247,732252,215270,113253,424
Equity
Equity, attributable to parent 63,85669,78572,07619,38039,646
Common stock 1818171010
Treasury stock, value (4,235)(4,154)(4,120)(4,027)(4,026)
Additional paid in capital 730,729728,094722,478643,150640,789
Accumulated other comprehensive income 1,8162,4692,5781,9902,588
Accumulated deficit (664,472)(656,642)(648,877)(621,743)(599,715)
Total equity: 63,85669,78572,07619,38039,646
TOTAL LIABILITIES AND EQUITY: 307,164317,517324,291289,493293,070

Income Statement (P&L) ($ in thousands)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
Revenues 35,75135,77536,23835,60634,693
Cost of revenue
(Cost of Product and Service Sold)
 (13,922)(12,701)(13,254)(12,407)(23,327)
Gross profit: 21,82923,07422,98423,19911,366
Operating expenses (31,687)(33,904)(32,851)(35,193)(35,062)
Operating loss: (9,858)(10,830)(9,867)(11,994)(23,696)
Nonoperating income (expense) 7982,784(20,520)(9,995)(2,252)
Investment income, nonoperating      12,100
Interest and debt expense  (8,527)(11,756)(8,490) 
Other undisclosed income from continuing operations before equity method investments, income taxes  8,52711,7568,490 
Loss from continuing operations before income taxes: (9,060)(8,046)(30,387)(21,989)(25,948)
Income tax expense (benefit) 1,2302813,253(39)(7)
Loss from continuing operations: (7,830)(7,765)(27,134)(22,028)(25,955)
Loss before gain (loss) on sale of properties:(7,830)(7,765)(27,134)(22,028)(25,955)
Net loss available to common stockholders, diluted: (7,830)(7,765)(27,134)(22,028)(25,955)

Comprehensive Income ($ in thousands)

6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
Net loss: (7,830)(7,765)(27,134)(22,028)(25,955)
Other comprehensive income (loss)  (109)588  
Comprehensive loss: (7,830)(7,874)(26,546)(22,028)(25,955)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (653)  (598)(100)
Comprehensive loss, net of tax, attributable to parent: (8,483)(7,874)(26,546)(22,626)(26,055)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: